This is usually given as an intramuscular injection, every 2-3 months
Dosing tiers: Oral administration (500 mcg to 1.5 mg/day) targets gut-specific inflammation: IBD, colitis, and intestinal barrier dysfunction
doi:10.1093/scan/nsaa108 Kheradpezhouh E, Panjehshahin MR, Miri R, et al
Successful intravenous immunoglobulin treatment in pediatric severe DRESS syndrome
432 Patients with MS exhibit elevated levels of IgG antibodies targeting HSP70 family members, although autoantibodies against HSP27, HSP60, and HSP90 are not typically detected
Individuals with Medical Conditions : Conditions like Crohns disease, celiac disease, and pernicious anemia can impair B12 absorption